PFM Health Sciences’s Icon ICLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.36M | Sell |
57,500
-57,836
| -50% | -$7.9M | 0.58% | 54 |
|
|
2025
Q4 | $21M | Sell |
115,336
-18,347
| -14% | -$3.27M | 2.1% | 14 |
|
|
2025
Q3 | $23.4M | Buy |
133,683
+45,502
| +52% | +$7.62M | 1.8% | 17 |
|
|
2025
Q2 | $12.8M | Buy |
88,181
+47,143
| +115% | +$6.69M | 1.09% | 31 |
|
|
2025
Q1 | $7.18M | Sell |
41,038
-87,599
| -68% | -$17M | 0.52% | 38 |
|
|
2024
Q4 | $27M | Buy |
128,637
+12,105
| +10% | +$2.83M | 1.67% | 19 |
|
|
2024
Q3 | $33.5M | Hold |
116,532
| – | – | 1.9% | 17 |
|
|
2024
Q2 | $36.5M | Buy |
116,532
+806
| +0.7% | +$253K | 1.81% | 19 |
|
|
2024
Q1 | $38.9M | Buy |
115,726
+13,914
| +14% | +$4.1M | 1.83% | 18 |
|
|
2023
Q4 | $28.8M | Sell |
101,812
-111,747
| -52% | -$28.9M | 1.73% | 21 |
|
|
2023
Q3 | $52.6M | Hold |
213,559
| – | – | 2.48% | 10 |
|
|
2023
Q2 | $53.4M | Buy |
213,559
+149,142
| +232% | +$31.7M | 2.07% | 15 |
|
|
2023
Q1 | $13.8M | Sell |
64,417
-17,308
| -21% | -$3.85M | 0.61% | 54 |
|
|
2022
Q4 | $15.9M | Sell |
81,725
-53,015
| -39% | -$10.5M | 0.57% | 59 |
|
|
2022
Q3 | $24.8M | Sell |
134,740
-23,443
| -15% | -$5.1M | 0.9% | 49 |
|
|
2022
Q2 | $34.3M | Hold |
158,183
| – | – | 1.31% | 32 |
|
|
2022
Q1 | $38.5M | Hold |
158,183
| – | – | 1.44% | 31 |
|
|
2021
Q4 | $49M | Hold |
158,183
| – | – | 1.67% | 24 |
|
|
2021
Q3 | $41.4M | Buy |
158,183
+13,956
| +10% | +$3.39M | 1.22% | 37 |
|
|
2021
Q2 | $29.8M | Buy |
144,227
+78,364
| +119% | +$16.9M | 0.93% | 40 |
|
|
2021
Q1 | $12.9M | Sell |
65,863
-55,460
| -46% | -$10.9M | 0.4% | 60 |
|
|
2020
Q4 | $23.7M | Hold |
121,323
| – | – | 0.83% | 48 |
|
|
2020
Q3 | $23.2M | Buy |
121,323
+18,357
| +18% | +$3.37M | 1.07% | 36 |
|
|
2020
Q2 | $17.3M | Buy |
102,966
+10,520
| +11% | +$1.66M | 0.9% | 41 |
|
|
2020
Q1 | $12.6M | Sell |
92,446
-101,131
| -52% | -$16.2M | 1.03% | 36 |
|
|
2019
Q4 | $33.3M | Sell |
193,577
-43,598
| -18% | -$6.72M | 1.59% | 23 |
|
|
2019
Q3 | $34.9M | Buy |
237,175
+106,800
| +82% | +$16.4M | 1.03% | 36 |
|
|
2019
Q2 | $20.1M | Buy |
+130,375
| New | +$18.3M | 0.38% | 64 |
|
|
2018
Q4 | – | Sell |
-299,037
| Closed | -$46M | – | 107 |
|
|
2018
Q3 | $46M | Sell |
299,037
-133,275
| -31% | -$19.1M | 0.67% | 55 |
|
|
2018
Q2 | $57.3M | Buy |
432,312
+163,959
| +61% | +$20.4M | 0.9% | 40 |
|
|
2018
Q1 | $31.7M | Sell |
268,353
-62,626
| -19% | -$7.18M | 0.64% | 60 |
|
|
2017
Q4 | $37.1M | Buy |
330,979
+47,784
| +17% | +$5.51M | 0.88% | 47 |
|
|
2017
Q3 | $32.3M | Buy |
283,195
+63,005
| +29% | +$6.7M | 0.63% | 55 |
|
|
2017
Q2 | $21.5M | Sell |
220,190
-67,878
| -24% | -$6M | 0.58% | 55 |
|
|
2017
Q1 | $23M | Buy |
+288,068
| New | +$23.6M | 0.58% | 61 |
|
|
2016
Q4 | – | Sell |
-195,089
| Closed | -$15.1M | – | 108 |
|
|
2016
Q3 | $15.1M | Buy |
+195,089
| New | +$14.7M | 0.44% | 64 |
|
Other funds holding ICLR
BWA
SHCM
PFM Health Sciences's ICLR Position: Q1 2026 in Review
PFM Health Sciences reduced its Icon (ICLR) stake by 50% in Q1 2026, selling an estimated $7.9M and leaving 57,500 shares worth $6.36M. The position accounts for 0.58% of the portfolio, ranked #54.
PFM Health Sciences first reported a position in ICLR in Q3 2016 and has held it in 36 quarters since. The position peaked at $57.3M in Q2 2018. 415 funds tracked by Wall St. Rank hold ICLR as of Q1 2026.
- PFM Health Sciences held 57,500 shares of Icon worth $6.36M as of Q1 2026.
- PFM Health Sciences sold 57,836 Icon shares in Q1 2026, an estimated $7.9M.
- Icon made up 0.58% of PFM Health Sciences's portfolio in Q1 2026, its #54 holding.
- PFM Health Sciences first reported a position in Icon in Q3 2016 and has held it in 36 quarters since.
- PFM Health Sciences's Icon position peaked at $57.3M in Q2 2018.
- 415 funds tracked by Wall St. Rank held Icon as of Q1 2026.
Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.